The latest fair value estimate for Myriad Genetics has shifted only slightly, now at US$8.32 compared with US$8.52 before, with the discount rate essentially steady at 7.62% and revenue growth in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback